29 research outputs found
Perforación duodenal espontánea en paciente intervenido de prostatectomía radical
Radical prostatectomy is a well known treatment for prostate cancer, with a low incidence of early postoperative complications. Our case is a 54 year old patient diagnosed with prostate adenocarcinoma, Gleason score 3+3=6 with 8 ng/ml of PSA, treated by retropubic prostatectomy, who suffered spontaneous perforation of the duodenum. We chose a conservative management, resolved in 30 days. When dealing with a surgical patient all kinds of complications must be taken into account by performing the minimum tests that will enable a sure diagnosis to be achieved. The usual treatment is surgery or conservative management, depending on the case and the patient
¿Existe un intervalo de tiempo de isquemia fría seguro para el injerto renal?
Objective: It is aimed to characterize the true relationship of the cold ischemia time (CIT) with
graft survival and with the principal post-transplantation events.aterial and methods: We analyzed 378 kidney transplants, studying the relationship of the
CIT with graft survival using a univariate analysis according to the COX model and seeking
the optimum cutoff according to the Kaplan-Meier method and log-rank test. The relationship
between CIT and the principal events of the post-transplant was studied using the binary logistic
regression.
Results: The mean follow-up of all the group was 77.8 months (±
51 SD) and the mean CIT was
14.8 hours (±
5.1 SD). The univariate analysis revealed that the CIT was not related with the
graft survival as a continuous variable (OR = 1.04; 95% CI: 0.9-1.08; p > 0.05). On establishing
the cutoff at 18 hours, we found differences in the actuarial survival. Survival at 5 years was
91% with CIT 18 h. Each hour of cold ischemia increased risk of
delay in the graft function by 10% (OR = 1.1; 95% CI: 1.05-1.15; p < 0.001) and also conditioned
a greater incidence of acute rejection (41.5% vs. 55.3%; p = 0.02) and less time to the first
rejection episode (72.6 days
±
137 vs. 272.2 days
±
614.8; p = 0.023) after 18 hours. The CIT
did not seem to be related (p < 0.05) with the rest of the post-transplantation events, such as
surgical complications or hospital admissions.
Conclusions: In our experience, cold ischemia under 18 hours does not seem to negatively affect
graft survival
Valor de la PET en la recurrencia del cáncer de próstata con PSA < 5 ng/ml
We intend to evaluate the usefulness of PET scans in diagnosing recurrent prostate cancer after a curative attempt using radical treatment.
MATERIAL AND METHODS:
92 consecutive prostate cancer patients in biochemical progression following radical surgery (63) or radiation treatment (29) were studied with positron emission tomography (PET). In all cases two scans were performed in the same day (11C-choline and 18F-FDG). PET efficacy was evaluated both globally (by employing the results achieved with both 11C-choline and 18F-FDG) and using both radiotracers independently to detect recurrence in patients with biochemical progression. For this purpose, we used comparison of means for k-independent samples, 2 x 2 and 2 x X contingency tables and ROC curves.
RESULTS:
1. Global PET: there is evidence of PET alteration regarding the PSA level (P=.003): the clinical stage (P=.01). There are no statistically significant PET alterations regarding the affected biopsy (uni or bilateral), surgical margins, pathological stage and time to progression. ROC curve PET-PSA is statistically significant (P< .0001) permitting calculation of different cut-off points, with a specificity of 91% (highest) for a PSA of 4.3 ng/ml. 2. PET 18FDG: the area under the ROC curve is statistically significant (P< .0001) with a specificity of 91% for a PSA of 6.51 ng/ml. 3. PET 11choline: the area under the ROC curve is statistically significant (P< .0001) with a specificity of 91% for a PSA of 5.15 ng/ml.
CONCLUSIONS:
PET is a useful tool for diagnosing prostate cancer recurrence after a curative attempt using radical treatment
Edad del donante y su influencia en la supervivencia del injerto
INTRODUCTION:
In 2007 in Spain 43% of donors were older than 60 years. This produces a worse graft quality and probably a worse survival.
OBJECTIVE:
Our objective is to analyze the influence of donor age on graft survival.
MATERIAL AND METHODS:
We analyze retrospectively 216 renal consecutive transplants realized between 2000 and 2008. A univaried and multivaried study (Cox regression) was performed and Kaplan-Meyer test with log rank for graft survival.
RESULTS:
Follow-up mean of 40 months (+/-33,4 SD). The univaried analysis of graft survival showed that donor age had a significative influence on graft survival. (OR=1,03; 95% CI 1,01-1,05) (p: 0,009). Studying the relation between donor and recipient age we find an inverse correlation (Pearson's Correlation: 0,55. p<0,0001), but there are significative differences after the adjustment for recipient age. (OR: 1,02; 95% CI 1,01-1,04) (p: 0,04). Optimal cut-point value determined by the ROC analysis was 60 years. The graft survival of donors over 60 years is 79% (95% CI; 74-84%) and 71% (95% CI; 65-77%) at 3 and 5 years in contrast with 94% (95% CI; 94-96%) and 90% (95% CI; 88-92 in donors under 60. (p: 0,002). The multivaried study of the influential factors on graft survival reveals that donor age dichotomized in older or younger than 60, the presence of a surgical immediate reintervention and a delayed graft function were independent influence factors.
CONCLUSIONS:
Donor age over 60 years has a negative and independent prognostic influence on graft survival
Litiasis renal secundaria a Indinavir
Indinavir sulphate is a protease inhibitor that has been found to be extremely effective in increasing CD4+ cell counts and in decreasing HIV-RNA titers in patients with HIV and AIDS. However, patients receiving indinavir also have been noted to have a significant risk of developing urolithiasis.
Indinavir has high urinary excretion with poor solubility in a physiologic pH solution.
The typical symptoms of indinavir urolithiasis are similar to other forms of urolithiasis. Indinavir urolithiasis is unique in that computed tomography, which was once thought to be efficacious in identifying all urinary calculi, is not useful in imaging stones that are composed of pure indinavir. Indinavir urolithiasis generally responds to a conservative regimen of hydration, pain control, and temporary discontinuation of the medication. Only a minority of patients need surgical intervention.Sulfato de indinavir es un inhibidor de la proteasa el cual se ha demostrado muy efectivo, incrementando los valores de células CD4+ y disminuyendo los títulos de ARN-VIH en pacientes VIH positivos y SIDA.
No obstante, en pacientes que han recibido tratamiento con indinavir, se ha notificado un incrimento de litiasis renal.
Indinavir tiene una alta excreción urinaria con una pobre solubilidad en pH urinario fisiológico.
La sintomatología clínica es similar a los otros tipos de litiasis renal. Las litiasis por indinavir son las únicas en la que la TAC no es capaz de visualizarlas.
El tratamiento conservador mediante hidratación y analgesia suele ser suficiente para resolver el cuadro, solo una minoría de pacientes necesitan procedimientos mas agresivos
Factores influyentes en el tiempo hasta la progresión bioquímica después de prostatectomía radical
INTRODUCTION:
We assessed the time-influencing clinical-pathological factors for biochemical progression of an equal series of patients from a single institution.
MATERIALS AND METHODS:
Retrospective analysis of 278 patients with biochemical progression following prostatectomy. We considered biochemical progression to be PSA>0.4 ng/ml. We performed the trial using the Cox model (univariate and multivariate) and using the Student's t-test to compare averages.
RESULTS:
With a mean follow-up of 4 (±3 DE) years, the univariate study showed a mean until progression for the Gleason score 2-6 in the biopsy of 824 days and 543 for the Gleason score 7-10 (p=0.003). For negative surgical margins, the mean was 920 days and 545 for positive margins (p=0.0001). In the case of a Gleason score 2-7 in the specimen, the mean was 806 days and 501 for a Gleason score 8-10 (p=0.001). Lastly, the mean for the cases with Ki-67 negative in the specimen ( 10%) (p=0.003). In the multivariate study, Ki-67 (OR 1.028; IC 95% 1-1.01; p=0.0001) and Gleason score 8-10 (OR 1.62; IC 95% 1.5-2.45; p=0.026) in the specimen, and initial PSA >10 ng/ml (OR 1.02; IC 95% 1.01-1.04; p=0.0001) were independent variables. Using these variables, we designed a predictive model with three groups. The time until the progression of each group was 1,081, 551 and 218 days respectively.
CONCLUSION:
The Gleason score 7-10 in the prostate biopsy, the presence of Ki-67, the positive margins and the Gleason score 8-10 in the specimen, and the initial PSA > 10 ng/ml are time-influencing factors until biochemical progression. Pathological Gleason score 8-10, PSA > 10 ng/ml and Ki-67 are independent factors
Complicaciones quirúrgicas en el trasplante renal y su influencia en la supervivencia del injerto
Objectives: To analyze surgical complications in kidney transplantation and their influence
on graft survival.
Materials and methods: A retrospective analysis was made of the early and late surgical
complications occurring in 216 consecutive kidney transplants performed at our institution
and their influence on graf tsurvival.
Results: At least one surgical complication occurred in 82(38%)of the 216 transplantations,
and 68(31%)required some type of repeat surgery,23 in the early post operative period and
45 more than 3 months after surgery. Mean follow–up was 48 months(SD þ/ 33.4), and
median follow–up 48 months(range,0–166months).
No recipient or donor factor spredisposing to surgical complications were found.
Graft survival was significantly shorter in patients with surgical complications [3-and
5-year survival rates of 86%(95%CI83%–89%)and 78%(95%CI73%–82%)as compared to
92% (95%CI90%–94%)and 88%(95%CI85%–91%),p:0.004].Early repeat surgery, venous thrombosis, and wound infection were among the complications having an independent
influence on graft survival.
A multivariate analysis of graft survival in the whole groups howed early repeat surgery
to bea factor with an independent prognostic value (OR:4.7;95%CI2.2–10,po0.0001).
Delayed function and donor age older than 60 years were the other independent influential
factors.
Conclusion: Surgical complications have an influence on graft survival.Then eed for early
repeat surgery, delayed function, and donor age older than 60 years are independent
predictors of graft survival
Impact of renal retransplantation on graft and recipient survival
The aim of this study was to evaluate the influence of
retransplantation in graft and recipient survival. METHODS: We carried out a
retrospective study in 419 renal transplants and studied the influence of
retransplantation in graft and patient survival. A homogeneity study was
performed between the two groups with a Student`s T and a chi-square tests. Graft
survival analysis was performed with Kaplan-Meyer and log rank tests. RESULTS: Of
419 transplants, 370 (88.3%) were first transplantations, 45 (10.7%) second
transplantations and 4(1%) third ones. Mean follow-up of the whole group was 72.5
months (+/-54.1 SD). There were no differences in follow-up between groups (Mean
Follow-up 73.1 months +/-54.4 SD in first transplantations vs. 61.6 months
+/-51.2 SD in repeat transplantation. p >0.05). The actuarial graft survival
showed no differences between patients with first transplantation and those with
a repeat one. [3 and 5 year SV of 89% (95% CI: 87-91%) and 84%(95% CI: 82-86%) Vs
88% (95% CI; 83-93%) and 85% (95% CI:i; 80-90%) respectively]. After adjusting
for all the heterogeneity variables we still did not find differences on graft
survival. The actuarial recipient survival showed no differences between patients
with first transplantation and those with a repeat one. [3 and 5 year SV of 98%
and 96% Vs.97%]. CONCLUSIONS: There are no differences of graft and recipient
survival between patients with a first transplantation and those with a repeat
one
Cáncer de próstata localizado de alto riesgo tratado mediante prostatectomía radical. Pronóstico y estudio de variables influyentes
Fundamento. Estudiar la supervivencia libre de progresión bioquímica
(SLPB) que ha obtenido un grupo de pacientes de alto riesgo de acuerdo
con la clasificación de D’Amico mediante prostatectomía radical.
Identificar las variables clínico-patológicas influyentes en la supervivencia libre de progresión bioquímica y diseñar con ellas, si es posible, un modelo pronóstico.
Material y métodos. Se estudian 232 pacientes, de una serie de 1.054,
diagnosticados de cáncer de próstata clínicamente localizado y calificados de alto riesgo en la clasificación de D’Amico (PSA >20 ng/ml ó Gleason
8-10 ó T3) tratados mediante prostatectomía radical.
Se estudia la SLPB y se analizan las variables clínico-patológicas
recogidas (PSA, Gleason de la biopsia y de la pieza, estadio clínico y patológico, afectación unilateral o bilateral, márgenes de la pieza de prostatectomía, expresión de Ki-67) para identificar si influyen en la SLPB.
Se ha utilizado para el estudio estadístico: tablas de contingencia
y para el análisis de la supervivencia: Kaplan-Meyer, Log-rank y modelos
de Cox.
Resultados. Estudio descriptivo: PSA: 23,3 ng/ml (mediana); cGleason 2-6:
33%; 7: 13%; 8-10: 54%; T2: 58%; Afectación bilateral en la biopsia diagnóstica: 59%; RNM T2: 60%; RNM T3: 40%. pGleason 2-6: 24%; 7: 28%; 8-10: 48%;
pT2: 43%; pT3a: 30%; pT3b: 27%; Margen afectado: 51%; N1:13%.
Supervivencia libre de progresión: con una media y mediana de seguimiento de 64 meses; el 53% evidencia progresión bioquímica. La mediana hasta progresión: 42 meses. La supervivencia libre de progresión
a 5 y 10 años es 43±3% y 26±7%. El estudio multivariado (modelos de
Cox) evidencia que las variables influyentes de forma independiente en
la SLPB son la afectación de márgenes (HR: 3,5; 95% IC.1,9-6,7; p<0001);
y Ki67 >10% (HR: 2,3; 95% IC: 1,2-4,3; P: 0,009).
Grupos de riesgo: utilizando las dos variables influyentes y utilizando modelos de Cox se diseñan tres grupos de riesgo como mejor modelo:
Grupo 1 (0 variables presentes); Grupo 2 (1 variable); Grupo 3 (2 variables). La supervivencia libre de progresión es de 69±8%; 27±6% y 18±11% a
los 5 años. Las diferencias son significativas entre los tres grupos.
Conclusión. El grupo de alto riesgo de la clasificación de D’Amico es heterogéneo en relación con la progresión bioquímica y puede ser desglosado en tres grupos de riesgo utilizando las dos variables de influencia
independiente (márgenes afectados y porcentaje de Ki67)
Estudio de los hallazgos de la gammagrafía renal inmediata y su influencia en la supervivencia del injerto renal
Introduction: We assessed the effect of the findings of the renal gammagraphy (99mTc-DTPA)
taken in the first 24 hours after the transplant in the survival of the kidney transplant.
Materials and method: We retrospectively studied 413 kidney transplants carried out between
January 1994 and December 2008, with emphasis on normal gammagraphic findings or alterations
in the vascular, parenchymal and excretory stages, as well as their effect on the survival
of the graft.
Results: Of the 413 transplants, 44 (10.7%) presented alterations in the vascular stage, 256 (62%)
in the parenchymal stage and 269 (65.1%) in the excretory stage. The mean follow-up of the
entire group was 72.5 months (± 54.1 DE). The univariate analysis shows that the survival of the
graft is significantly less in patients with alterations in the vascular stage (OR: 3; IC 95% 1.9 — 4.9
p < 0.001), in the excretory stage (OR: 2.5; IC 95% 1.5 - 4; p = <0.001) in the parenchymal stage
(OR: 2.21; IC 95% 1.3-3.36; p = 0.001). The multivariate studies of the gammagraphic variables
that affect the survival of the graft show that the presence of alterations in the vascular stage
(OR: 3; IC 95% 1.9-4.9; p < 0.001) in the parenchymal stage (OR: 2; IC 95% 1.2-3.3; p = 0.005)
are directly related to survival. This data is also confirmed by means of the actuarial survival
analysis of the graft at 3 and 5 years.
Conclusions: The presence of alterations in the vascular stage and in the parenchymal stage of
the renal gammagraphy immediately after the transplant are variables that affect the survival
of the graft